BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10355150)

  • 1. [Pranlukast allows reduction of inhaled steroid dose without deterioration in lung function in adult asthmatics].
    Tomita K; Hashimoto K; Matsumoto S; Nakamoto N; Tokuyasu H; Yamasaki A; Yajima H; Sasaki T; Kawasaki Y; Fukutani K
    Arerugi; 1999 Apr; 48(4):459-65. PubMed ID: 10355150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of theophylline or pranlukast, a cysteinyl leukotriene receptor 1 antagonist, as add-on therapy in uncontrolled asthmatic patients with a medium dose of inhaled corticosteroids.
    Tsuchida T; Matsuse H; Machida I; Kondo Y; Saeki S; Tomari S; Obase Y; Matsuo N; Shimoda T; Kohno S
    Allergy Asthma Proc; 2005; 26(4):287-91. PubMed ID: 16270722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pranlukast, a cysteinyl leukotriene receptor 1 antagonist, combined with inhaled beclomethasone in patients with moderate or severe asthma.
    Tomari S; Shimoda T; Kawano T; Mitsuta K; Obase Y; Fukushima C; Matsuse H; Kohno S
    Ann Allergy Asthma Immunol; 2001 Aug; 87(2):156-61. PubMed ID: 11527250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of add-on pranlukast in stable asthma; the additive effect on peripheral airway inflammation.
    Yasui H; Fujisawa T; Inui N; Kato M; Hashimoto D; Enomoto N; Nakamura Y; Shirai T; Suda T; Nakamura H; Chida K
    Respir Med; 2012 Apr; 106(4):508-14. PubMed ID: 22265857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical effects of long-term administration of pranlukast, a leukotriene receptor antagonist, on adult patients with bronchial asthma].
    Horiguchi T; Kondo R; Miyazaki J; Shiga M; Sugiyama M; Hirose M; Tachikawa S
    Nihon Kokyuki Gakkai Zasshi; 2003 Oct; 41(10):696-703. PubMed ID: 14584388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the combined effect of pranlukast during high-dose steroid inhalation.
    Horiguchi T; Tachikawa S; Kondo R; Miyazaki J; Sasaki Y; Banno K; Handa M
    Arzneimittelforschung; 2002; 52(11):813-6. PubMed ID: 12489251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of regular treatment with inhaled corticosteroid or leukotriene receptor antagonist in mild intermittent asthma.
    Tamaoki J; Isono K; Taira M; Tagaya E; Nakata J; Kawatani K; Nagai A
    Allergy Asthma Proc; 2008; 29(2):189-96. PubMed ID: 18430318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled beclomethasone dipropionate (BDP) prevents seasonal changes in atopic asthmatics.
    Ponticiello A; Vatrella A; Parrella R; Romano L; Zofra S; Berlingieri GM; Bariffi F
    Monaldi Arch Chest Dis; 1997 Apr; 52(2):112-7. PubMed ID: 9203805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of the leukotriene receptor antagonist pranlukast versus the steroid inhalant fluticasone in the therapy of aged patients with mild bronchial asthma.
    Horiguchi T; Tachikawa S; Kondo R; Miyazaki J; Shiga M; Hirose M; Kobayashi K; Hayashi N; Ohira D; Nasu T; Otake Y; Hata H
    Arzneimittelforschung; 2007; 57(2):87-91. PubMed ID: 17396618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equally efficacious asthma management with budesonide 800 micrograms administered by Turbuhaler or with beclomethasone dipropionate > or = 1500 micrograms given through a pressurized metered-dose inhaler with spacer. The French Budesonide Trial Group.
    Piquet J; Zuck P; Dennewald G; Dugue P; Grivaux M; Brun P; Severac JC; Ostinelli J; Cheeseman KH
    Adv Ther; 1996; 13(1):38-50. PubMed ID: 10172710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new beclomethasone dipropionate multidose powder inhaler in the treatment of bronchial asthma.
    Nieminen MM; Vidgren P; Kokkarinen J; Laasonen K; Liippo K; Lindqvist A; Paananen M; Poukkula A; Ruotsalainen E; Salomaa E; Sovijärvi A; Söderblom T; Silvasti M; Vidgren M; Laitinen LA
    Respiration; 1998; 65(4):275-81. PubMed ID: 9730793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group.
    Tamaoki J; Kondo M; Sakai N; Nakata J; Takemura H; Nagai A; Takizawa T; Konno K
    Am J Respir Crit Care Med; 1997 Apr; 155(4):1235-40. PubMed ID: 9105060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once daily nebulized beclomethasone is effective in maintaining pulmonary function and improving symptoms in asthmatic children.
    La Grutta S; Nicolini G; Capristo C; Bellodi SC; Rossi GA
    Monaldi Arch Chest Dis; 2007 Mar; 67(1):30-8. PubMed ID: 17564282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of pulmonary function in bronchial asthma patients treated with pranlukast.
    Yanagawa H; Sugita A; Azuma M; Ogawa H; Kitamuro C; Yoneda K; Shinkawa K; Tani K; Sone S
    Lung; 2004; 182(1):51-8. PubMed ID: 14752672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effect of pranlukast, a selective cysteinyl leukotriene receptor antagonist, on bronchial asthma.
    Oosaki R; Mizushima Y; Kashii T; Kawasaki A; Kobayashi M
    Int Arch Allergy Immunol; 1997 Sep; 114(1):97-100. PubMed ID: 9303339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparable effect of a leukotriene receptor antagonist and long-acting beta₂-adrenergic agonist in cough variant asthma.
    Tamaoki J; Yokohori N; Tagaya E; Kirishi S; Miyamoto Y; Ochiai K; Kondo M; Nagai A
    Allergy Asthma Proc; 2010; 31(5):78-84. PubMed ID: 20929598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pranlukast: a review of its use in the management of asthma.
    Keam SJ; Lyseng-Williamson KA; Goa KL
    Drugs; 2003; 63(10):991-1019. PubMed ID: 12699401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pranlukast, a leukotriene receptor antagonist, in patients with severe asthma refractory to corticosteroids.
    Yokoyama A; Kohno N; Sakai K; Hirasawa Y; Kondo K; Hiwada K
    J Asthma; 1998; 35(1):57-62. PubMed ID: 9513583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of inhaled beclomethasone dipropionate and budesonide dry powder on pulmonary function and serum eosinophil cationic protein in adult asthmatics.
    Dal Negro R; Micheletto C; Tognella S; Mauroner L; Burti E; Turco P; Pomari C; Cantini L
    J Investig Allergol Clin Immunol; 1999; 9(4):241-7. PubMed ID: 10513351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of fluticasone propionate at half dose of beclomethasone dipropionate divided twice daily and once daily in asthmatics inhaling beclomethasone dipropionate 800 micrograms daily or more].
    Hasegawa T; Tomii K; Kikumoto N; Sakamoto H; Maekawa T; Katayama S; Kamei T; Sakamoto Y; Fujii H; Ishihara K
    Arerugi; 2001 Apr; 50(4):379-84. PubMed ID: 11398334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.